Sonorous Neurovascular earns FDA clearance for next-gen neurovascular catheter
April 22, 2026
Sonorous Neurovascular announced today that it received FDA 510(k) clearance for its BosCATH next-generation neurovascular catheter.
Sonorous Neurovascular announced today that it received FDA 510(k) clearance for its BosCATH next-generation neurovascular catheter.
Luminoah announced today that it received FDA clearance for Luminoah Flow, an enteral feeding system for those who rely on tube feeding.
Broader indications reinforce SINEFIX as a versatile alternative to traditional suture anchors for soft tissue-to-bone fixation.
EXETER, N.H., April 21, 2026 /PRNewswire/ — Vapotherm, Inc., a developer and manufacturer of advanced respiratory technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its All Patient Circuit (APC™) which now includes therapy settings for neonatal and infant patients. The cleared APC enables the HVT 2.0 high velocity therapy system to deliver therapy across a 2–45 L/min flow range using a single disposable patient circuit.
LEXINGTON, Mass., April 21, 2026 (GLOBE NEWSWIRE) — Hyalex Orthopaedics today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its HYALEX Slalom™ MTP Hemiarthroplasty Implant, a next-generation implant designed around the proprietary Hydrosurf™ materials platform, for the treatment of degenerative conditions affecting the first metatarsophalangeal (MTP) joint, including hallux rigidus.
BVI Medical announced today that it received CE mark for its Virtuoso next-generation phaco-vitrectomy surgical platform.
Conavi Medical announced today that it received FDA 510(k) clearance for its next-generation hybrid imaging system.
Fentanyl Urine Visual Test is available through Labcorp Point of Care, previously known as MEDTOX Diagnostics
MONTREAL, April 17, 2026 /PRNewswire/ — Bracco Imaging, a global leader in diagnostic imaging, today announced that Health Canada approved VUEWAY® injection (gadopiclenol), a macrocyclic gadolinium-based contrast agent (GBCA), for use in contrast-enhanced magnetic resonance imaging (CE-MRI).
PITTSBURGH, April 17, 2026 /PRNewswire/ — Xodus Medical today announced the launch of the Hot Pink Pad®, a next-generation patient temperature management and positioning system designed to improve surgical outcomes, enhance patient safety, and streamline operating room workflows.